Medical Xpress

FEBRUARY 3, 2023

Patients can experience 30% fewer serious adverse reactions if their drugs are tailored to their genes, reports a study published in The Lancet. A European collaboration involving researchers from Karolinska Institutet suggests that a genetic analysis prior to drug therapy could significantly reduce suffering and health care costs.

Genetic Analysis 96

Genetic Analysis Genetics Drugs Gene 96

pharmaphorum

APRIL 5, 2022

The technique uses artificial intelligence (AI) to analyse protein data harvested from tumour cells, using an algorithm trained by looking at changes to 52 proteins when they are exposed to a panel of targeted anticancer drugs. The post AI test could predict best cancer therapies for patients appeared first on.

Protein 67

Protein Genome Genomics Genetic Analysis 67

pharmaphorum

NOVEMBER 16, 2022

But combined, OAKS and DERBY were two phase 3 trials involving 1,258 patients […] randomised equally to one of three arms essentially: pegcetacoplan 15mg monthly, same drug same dose every other month, or sham treatment through two complete years,” Dr Wykoff said. After all, GA is almost impossible to treat. About the interviewee.

Genetics 105

Genetics Trials Clinical Trials Clinical Trials 105

FDA Law Blog

MARCH 13, 2023

Bauer, Senior Regulatory Drug Expert & James E. Valentine — Incorporating patient and caregiver experiences into every phase of drug development has become increasingly prioritized during both development and review ( see, e.g. , previous coverage here ). There have been challenges in gene therapy development. By Larry J.

Gene Therapy 98

Gene Therapy Gene Trials Clinical Trials 98

Delveinsight

FEBRUARY 25, 2021

Beam adds to drug delivery stable with USD 120 Million GuideTx buy. Beam Therapeutics has taken over a startup whose technology could proffer the biotech’s genetic medicines to more tissues in the body, widening the potential to approach more diseases. If they eliminated the T cells, the therapy stopped working.

DNA 52

DNA In-Vivo Genetics Medicine 52

The Pharma Data

APRIL 8, 2022

They also identified several drugs that reduced the production of inflammatory cytokines in infected Alveolus Chips, which could be useful in treating excessive inflammation in the lung. Based on these studies, one of those drugs was licensed to Cantex Pharmaceuticals for the treatment of COVID-19 and other inflammatory lung diseases.

Immune Response 52

Immune Response In-Vivo Genetic Analysis Research 52

XTalks

JANUARY 6, 2025

This blog highlights the top 10 biotech trends for 2025, showcasing cutting-edge technologies and approaches that promise to redefine patient care, accelerate drug development and expand our understanding of human biology. Furthermore, CRISPR/Cas9 presents a promising avenue for overcoming genetic diseases in the near future.

Gene Therapy 111

Gene Therapy RNA Gene Editing Gene 111